Company: IMRX
Filing Date: 2025-05-05
Form Type: 10-Q
Source: 0001790340-25-000061
Chunk: 331

Company: Immuneering Corp
Filing Date: 2025-05-05
Form: 10-Q
Item: Part I, Item 1
Chunk 331
---
 2 – Quoted prices for similar assets and liabilities in active markets, quoted prices in markets that are not active, or inputs which are observable, directly or indirectly, for substantially the full term of the asset or liability.Level 3 – Unobservable inputs that reflect our own assumptions about the assumptions market participants would use in pricing the asset or liability in which there is little, if any, market activity for the asset or liability at the measurement date.The following table summarizes our cash equivalents measured at fair value on a recurring basis as of March 31, 2025:Level 1Level 2Level 3TotalAssets:Cash equivalentsMoney market$35,577,746 $— $— $35,577,746 Total cash equivalents$35,577,746 $— $— $35,577,746 There have been no changes to the valuation methods during the three months ended March 31, 2025. There were no transfers between Level 1 and Level 2 and we had no financial assets or liabilities that were classified as Level 3 at any point during the three months ended March 31, 2025. 

14

Cash equivalents and marketable securities have been initially valued at the transaction price and subsequently, at the end of each reporting period, valued utilizing third-party pricing services or other observable market data. The pricing services utilize industry standard valuation models, including both income and market-based approaches, and observable market inputs to determine value. After completing our valuation procedures, we did not adjust or override any fair value measurements provided by the pricing services as of March 31, 2025 and December 31, 2024.The following table summarizes our cash equivalents measured at fair value on a recurring basis as of December 31, 2024:Level 1Level 2Level 3TotalAssets:Cash equivalentsMoney market$35,865,754 $— $— $35,865,754 Total cash equivalents$35,865,754 $— $— $35,865,754 

Note 5 – Property and Equipment, net

Property and equipment, net consisted of the following:March 31,2025December 31,2024Computer equipment$579,723 $570,778 Furniture and fixtures98,628 98,628 Lab equipment1,236,233 1,236,233 Leasehold improvements298,941 298,941 Total2,213